PL2421508T3 - Materiał w postaci cząstek do kontrolowanego uwalniania składników czynnych - Google Patents

Materiał w postaci cząstek do kontrolowanego uwalniania składników czynnych

Info

Publication number
PL2421508T3
PL2421508T3 PL10716464T PL10716464T PL2421508T3 PL 2421508 T3 PL2421508 T3 PL 2421508T3 PL 10716464 T PL10716464 T PL 10716464T PL 10716464 T PL10716464 T PL 10716464T PL 2421508 T3 PL2421508 T3 PL 2421508T3
Authority
PL
Poland
Prior art keywords
active ingredients
controlled release
particulate material
particulate
release
Prior art date
Application number
PL10716464T
Other languages
English (en)
Inventor
Kurt Møller Pedersen
Jette Baek Andersen
Original Assignee
Omya International Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42289647&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2421508(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Omya International Ag filed Critical Omya International Ag
Publication of PL2421508T3 publication Critical patent/PL2421508T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G4/00—Chewing gum
    • A23G4/06—Chewing gum characterised by the composition containing organic or inorganic compounds
    • A23G4/064—Chewing gum characterised by the composition containing organic or inorganic compounds containing inorganic compounds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G4/00—Chewing gum
    • A23G4/06—Chewing gum characterised by the composition containing organic or inorganic compounds
    • A23G4/12—Chewing gum characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G4/00—Chewing gum
    • A23G4/18—Chewing gum characterised by shape, structure or physical form, e.g. aerated products
    • A23G4/20—Composite products, e.g. centre-filled, multi-layer, laminated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A61K9/0058—Chewing gums
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Physiology (AREA)
  • Addiction (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Confectionery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compounds Of Alkaline-Earth Elements, Aluminum Or Rare-Earth Metals (AREA)
PL10716464T 2009-04-24 2010-04-26 Materiał w postaci cząstek do kontrolowanego uwalniania składników czynnych PL2421508T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US17247409P 2009-04-24 2009-04-24

Publications (1)

Publication Number Publication Date
PL2421508T3 true PL2421508T3 (pl) 2017-06-30

Family

ID=42289647

Family Applications (1)

Application Number Title Priority Date Filing Date
PL10716464T PL2421508T3 (pl) 2009-04-24 2010-04-26 Materiał w postaci cząstek do kontrolowanego uwalniania składników czynnych

Country Status (13)

Country Link
US (2) US20120321751A1 (pl)
EP (2) EP2421508B1 (pl)
JP (1) JP5732043B2 (pl)
KR (2) KR20170081748A (pl)
CN (1) CN102481257B (pl)
AU (1) AU2010238945B2 (pl)
CA (1) CA2758618C (pl)
CL (1) CL2011002627A1 (pl)
DK (1) DK2421508T3 (pl)
ES (1) ES2619556T3 (pl)
PL (1) PL2421508T3 (pl)
RU (1) RU2530655C2 (pl)
WO (2) WO2010121620A1 (pl)

Families Citing this family (76)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2168572A1 (en) 2008-09-30 2010-03-31 Omya Development Ag New controlled release active agent carrier
GB0911402D0 (en) * 2009-07-01 2009-08-12 Brightwake Ltd Propolis film
WO2011130414A1 (en) 2010-04-14 2011-10-20 Altria Client Services Inc. Preformed smokeless tobacco product
SG184523A1 (en) 2010-05-10 2012-11-29 Euro Celtique Sa Pharmaceutical compositions comprising hydromorphone and naloxone
MX340188B (es) 2010-05-10 2016-06-30 Euro-Celtique S A * Elaboracion de granulos sin activos y tabletas que comprenden los mismos.
WO2011141490A1 (en) 2010-05-10 2011-11-17 Euro-Celtique S.A. Combination of active loaded granules with additional actives
EP2680828A4 (en) * 2011-02-28 2014-07-30 Technologies Khlôros Inc COUGAR MEANS FOR ORAL ABSORPTION
CA2852788C (en) 2011-10-19 2019-02-12 Fertin Pharma A/S Nicotine chewing gum with improved utilization of nicotine
EP3075376A1 (en) 2011-11-10 2016-10-05 Omya International AG New coated controlled release active agent carriers
TWI625129B (zh) 2011-11-10 2018-06-01 歐米亞國際公司 新穎的經塗布控釋活性劑載體
WO2013091631A1 (en) * 2011-12-22 2013-06-27 Fertin Pharma A/S Method of releasing nicotine from chewing gum
SE536491C2 (sv) * 2012-03-26 2013-12-27 Bionicotine Ab Påse innehållande nikotin och en tuggummikomposition
EP2653042A1 (en) * 2012-04-20 2013-10-23 JT International SA pH-stabilized oral tobacco composition
WO2014151565A1 (en) 2013-03-15 2014-09-25 The Brigham And Women's Hospital, Inc. Compounds to modulate intestinal absorption of nutrients
US10799548B2 (en) * 2013-03-15 2020-10-13 Altria Client Services Llc Modifying taste and sensory irritation of smokeless tobacco and non-tobacco products
CA3208137A1 (en) 2013-05-06 2014-11-13 Juul Labs, Inc. Nicotine salt formulations for aerosol devices and methods thereof
JP6232135B2 (ja) 2013-11-13 2017-11-15 ユーロ−セルティーク エス．エイ． 疼痛およびオピオイドによる腸機能障害症候群の治療のためのヒドロモルホンおよびナロキソン
CN119606056A (zh) 2013-12-05 2025-03-14 尤尔实验室有限公司 用于气雾剂装置的尼古丁液体制剂及其方法
EP3129011B1 (en) * 2014-04-08 2023-06-07 Fertin Pharma A/S Medical chewing gum
AR101774A1 (es) * 2014-09-12 2017-01-11 Wrigley W M Jun Co Composición de goma de mascar que comprenden varios edulcorantes
CN107106422B (zh) 2014-12-15 2021-04-09 高露洁-棕榄公司 高盐牙膏及其使用方法
JP6479464B2 (ja) * 2014-12-26 2019-03-06 三栄源エフ・エフ・アイ株式会社 チューインガムからのアドバンテームの甘味の発現を調整する方法
CN105029676A (zh) * 2015-08-31 2015-11-11 湖北中烟工业有限责任公司 一种抗牙齿过敏的嚼烟
US10973846B2 (en) 2015-09-24 2021-04-13 The Brigham And Women's Hospital, Inc. Water-activated mucoadhesive compositions to reduce intestinal absorption of nutrients
US10485247B2 (en) 2015-10-07 2019-11-26 Fertin Pharma A/S Chewing gum comprising nicotine
EP3176222A1 (en) * 2015-12-01 2017-06-07 Omya International AG Method for the production of granules comprising surface-reacted calcium carbonate
EP3192850B1 (en) 2016-01-14 2018-10-03 Omya International AG Use of surface-treated calcium carbonate as oxygen scavenger
EP3192838A1 (en) 2016-01-14 2017-07-19 Omya International AG Treatment of surface-reacted calcium carbonate
CN105795087B (zh) * 2016-05-05 2023-04-11 宜兰食品工业股份有限公司 一种压片糖果及其制备方法
EP3275947A1 (en) * 2016-07-25 2018-01-31 Omya International AG Surface-reacted calcium carbonate with functional cations
WO2018020512A1 (en) 2016-07-26 2018-02-01 Parachur Vivek Anand Slow release composition of active ingredients
CN106361768A (zh) * 2016-08-29 2017-02-01 宋延军 一种用于辅助治疗高血压、糖尿病的组合物及其制剂
BR112019016663A2 (pt) * 2017-02-21 2020-04-07 Colgate Palmolive Co composições para higiene bucal e métodos de uso
EP3378502A1 (en) * 2017-03-23 2018-09-26 Omya International AG Use of zinc treated precipitated calcium carbonate in hygienic products
WO2018215479A1 (en) * 2017-05-24 2018-11-29 Philip Morris Products S.A. Homogenised botanical material comprising a basic ph modifier
SE541358C2 (en) * 2017-05-30 2019-08-13 Enorama Pharma Ab Nicotine-containing chewing gum compositions
PL3641726T3 (pl) 2017-06-23 2026-02-23 Nordiccan A/S Woreczek z kannabinoidami
EP3641731A1 (en) 2017-06-23 2020-04-29 Fertin Pharma A/S Nicotine pouch
WO2020012009A1 (en) * 2018-07-13 2020-01-16 Mcneil Ab Chewing gum comprising nicotine
EP3594289A1 (en) * 2018-07-13 2020-01-15 Omya International AG Surface-reacted calcium carbonate for stabilizing mint oil
CN111419462A (zh) * 2019-01-09 2020-07-17 曹荣华 一种口腔保健用品
CN110202860B (zh) * 2019-05-31 2021-04-23 华南农业大学 一种梯度缓释型的活性复合膜及其制备方法
GB2584649A (en) * 2019-06-06 2020-12-16 Pa Knowledge Ltd Infusion product and method of making an infusion product
DK180339B1 (en) 2019-06-07 2020-12-18 Ncp Nextgen As Nicotine pouch composition and pouch comprising such
MX2021014975A (es) 2019-06-07 2022-01-24 Philip Morris Products Sa Producto oral en bolsitas.
CN114269386A (zh) 2019-06-10 2022-04-01 布里格姆及妇女医院股份有限公司 水活化的粘膜粘附性组合物和递送生物活性物质的方法
WO2021011788A1 (en) * 2019-07-16 2021-01-21 Advanced Female Technologies Llc Chewing gum compositions for the treatment of menopausal symptoms
US11759419B2 (en) 2019-10-11 2023-09-19 Fertin Pharma A/S Compressed nicotine lozenge
US12702643B2 (en) * 2019-10-11 2026-08-11 Fertin Pharma A/S Ion-exchange composition with water-soluble mucoadhesive polymers
US11672862B2 (en) * 2019-12-09 2023-06-13 Nicoventures Trading Limited Oral products with reduced irritation
US11617744B2 (en) 2019-12-09 2023-04-04 Nico Ventures Trading Limited Moist oral compositions
JP2023505351A (ja) * 2019-12-09 2023-02-08 ニコベンチャーズ トレーディング リミテッド 口腔用組成物のための薬剤
US11889856B2 (en) 2019-12-09 2024-02-06 Nicoventures Trading Limited Oral foam composition
US12433321B2 (en) 2019-12-09 2025-10-07 Nicoventures Trading Limited Oral composition with beet material
US12520867B2 (en) 2019-12-09 2026-01-13 Nicoventures Trading Limited Buffered oral compositions
US12439952B2 (en) 2019-12-09 2025-10-14 Nicoventures Trading Limited Moist oral compositions
US11969502B2 (en) 2019-12-09 2024-04-30 Nicoventures Trading Limited Oral products
US12310959B2 (en) 2019-12-09 2025-05-27 Nicoventures Trading Limited Oral compositions with reduced water content
US20220304366A1 (en) * 2019-12-09 2022-09-29 Nicoventures Trading Limited Oral products with reduced irritation
US11826462B2 (en) 2019-12-09 2023-11-28 Nicoventures Trading Limited Oral product with sustained flavor release
US11793230B2 (en) 2019-12-09 2023-10-24 Nicoventures Trading Limited Oral products with improved binding of active ingredients
US12439949B2 (en) 2019-12-09 2025-10-14 Nicoventures Trading Limited Oral compositions with reduced water activity
US11872231B2 (en) 2019-12-09 2024-01-16 Nicoventures Trading Limited Moist oral product comprising an active ingredient
US20220295858A1 (en) * 2019-12-09 2022-09-22 Nicoventures Trading Limited Oral products with controlled release
CN111227427A (zh) * 2020-01-16 2020-06-05 浙江荣威鞋业有限公司 一种鞋底抗菌的鞋子及其制备工艺
CN111558033A (zh) * 2020-05-14 2020-08-21 广州中昱医学生物科技有限公司 一种口腔清洁组合物及其应用
CN115605207A (zh) * 2020-05-14 2023-01-13 葡默药物技术有限公司（Us） 用于经粘膜给药的固体剂型
LT4243797T (lt) * 2020-11-16 2026-06-10 Orcosa Inc. Greitos infuzijos platforma ir kompozicijos, skirtos žmonių terapiniam gydymui
US12382982B2 (en) 2021-06-25 2025-08-12 Nicoventures Trading Limited Oral products and method of manufacture
CA3238151A1 (en) * 2021-11-15 2023-05-19 Shahin ROOHINEJAD Oral products with nicotine-polymer complex
CN114532587B (zh) * 2022-01-12 2023-06-30 云南中烟工业有限责任公司 一种可调控缓释性能的改性Al2O3/香料复合材料的制备方法及其应用
US12121047B2 (en) 2022-06-14 2024-10-22 Botany Al, Inc. Dynamically delivering fat and flavor potentiators to foods and methods of use thereof
WO2023245070A2 (en) * 2022-06-14 2023-12-21 BOTANY AL, INC., dba UMMINO Dynamically delivering fat and flavor potentiators to foods and methods of use thereof
WO2024258969A2 (en) * 2023-06-15 2024-12-19 Botany AI, Inc., dba Ummino Dynamically delivering fat and flavor potentiators to foods and methods of use thereof
CN116725220A (zh) * 2023-06-16 2023-09-12 东莞市吉纯生物技术有限公司 一种以壳聚糖为基质的尼古丁口含制品及其制备方法
DK182139B1 (en) 2023-09-29 2025-09-04 Fertin Pharma As Nicotine pouch comprising particulate inorganic mineral filler

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1171392A (en) * 1913-10-09 1916-02-08 Adolphus G Meier Chewing-gum and method of making the same.
SE421042B (sv) * 1976-06-29 1981-11-23 Kockums Chem Sett att minska den for en viss biologisk effekt erforderliga mengden biologiskt aktiv substans
JPS5964527A (ja) * 1982-09-29 1984-04-12 Shiraishi Chuo Kenkyusho:Kk アモルファス炭酸カルシウムの製造方法
US4656039A (en) * 1985-07-11 1987-04-07 Nabisco Brands, Inc. Layered chewing gum with moisture impervious outer layer
US4753800A (en) 1985-10-04 1988-06-28 Warner-Lambert Company Medicament adsorbates and their preparation
US5399365A (en) * 1991-06-19 1995-03-21 Wm. Wrigley Jr. Company Chewing gum containing palatinose and/or palatinose oligosaccharide
WO1991015941A1 (en) * 1991-06-19 1991-10-31 Wm. Wrigley Jr. Company Chewing gum containing palatinose
JP3634404B2 (ja) * 1993-12-14 2005-03-30 丸尾カルシウム株式会社 多孔質炭酸カルシウム化合物及びその製造方法
US5556652A (en) * 1994-08-05 1996-09-17 Fuisz Technologies Ltd. Comestibles containing stabilized highly odorous flavor component delivery systems
KR0182788B1 (ko) * 1996-02-02 1999-04-15 유규재 초미세 교질 탄산칼슘의 제조방법
JP4110235B2 (ja) * 1996-12-25 2008-07-02 丸尾カルシウム株式会社 徐放体用花弁状多孔質基材及び徐放体組成物
CA2235655C (en) * 1997-04-24 2008-01-22 Sunstar Inc. Oral compositions comprising porous calcium carbonate
JP3834732B2 (ja) * 1998-08-05 2006-10-18 株式会社ロッテ チューインガム
US6344222B1 (en) * 1998-09-03 2002-02-05 Jsr Llc Medicated chewing gum delivery system for nicotine
US6541048B2 (en) * 1999-09-02 2003-04-01 Wm. Wrigley Jr. Company Coated chewing gum products containing an acid blocker and process of preparing
AU2294301A (en) * 1999-12-30 2001-07-16 Wm. Wrigley Jr. Company Controlled release perillartine in chewing gum
US6555145B1 (en) * 2000-06-06 2003-04-29 Capricorn Pharma, Inc. Alternate encapsulation process and products produced therefrom
JP3775569B2 (ja) * 2000-11-20 2006-05-17 有限会社ニューライム研究社 合成炭酸カルシウム系球状多孔質造粒体及びその製造方法
DK1663168T3 (da) * 2003-09-08 2009-06-08 Mcneil Ab Nikotinformuleringer og anvendelse deraf
US20050084551A1 (en) * 2003-09-26 2005-04-21 Jensen Claude J. Morinda citrifolia-based oral care compositions and methods
US7211275B2 (en) * 2004-01-16 2007-05-01 Massachusetts Institute Of Technology Composite materials for controlled release of water soluble products
JP2008515407A (ja) * 2004-10-08 2008-05-15 ガムリンク エー／エス 菓子製品
FR2881957B1 (fr) * 2005-02-16 2008-08-08 Solvay Comprimes comprenant une substance biologiquement active et un excipient
CN101534659B (zh) 2006-10-31 2013-08-21 Wm.雷格利Jr.公司 香料释放核心及其在口香糖中的应用
EP1974807B1 (en) * 2007-03-21 2010-03-03 Omya Development Ag Process for the removal of endocrine disrupting compounds
EP2168572A1 (en) * 2008-09-30 2010-03-31 Omya Development Ag New controlled release active agent carrier

Also Published As

Publication number Publication date
KR20170081748A (ko) 2017-07-12
EP2421508A1 (en) 2012-02-29
RU2011147588A (ru) 2013-05-27
CN102481257A (zh) 2012-05-30
US20120039981A1 (en) 2012-02-16
JP5732043B2 (ja) 2015-06-10
US20120321751A1 (en) 2012-12-20
EP2421508B1 (en) 2016-12-14
EP2421507B1 (en) 2019-01-23
CL2011002627A1 (es) 2012-07-06
WO2010121619A1 (en) 2010-10-28
KR20120023690A (ko) 2012-03-13
CA2758618A1 (en) 2010-10-28
KR101775169B1 (ko) 2017-09-05
CA2758618C (en) 2017-03-28
DK2421508T3 (en) 2017-03-27
RU2530655C2 (ru) 2014-10-10
EP2421507A1 (en) 2012-02-29
CN102481257B (zh) 2014-08-13
ES2619556T3 (es) 2017-06-26
AU2010238945B2 (en) 2013-10-24
JP2012524734A (ja) 2012-10-18
AU2010238945A1 (en) 2011-11-10
WO2010121620A1 (en) 2010-10-28

Similar Documents

Publication Publication Date Title
IL214624A0 (en) Controlled release pharmaceutical formulations of nitazoxanide
ZA201208336B (en) Controlled release pharmaceutical compositions of tapentadol
ZA201008882B (en) Controlled release of microbiocides
GB0905507D0 (en) Organopol Ysiloxane Compositions Containing An Active Material
AP2013006656A0 (en) Compositions for sustained release of agriculturalmacronutrients and process thereof
ZA201207552B (en) Microporous material
SG10201600803SA (en) Methods and compositions for highly specific capture and release of biological materials
PL2554168T3 (pl) Kompozycja farmaceutyczna do kontrolowanego uwalniania
ZA201204583B (en) Degradable removable implant for the sustained release of an active compound
GB0912177D0 (en) Contained transfer of material
GB2467838B (en) Means for distribution of fish
ZA201205988B (en) Plant disease controlling composition and method for controlling plant disease
PL2542072T3 (pl) Kompozycja do zwalczania chorób roślin i sposób zwalczania chorób roślin
PL2415463T3 (pl) Kompozycja lecznicza w postaci cząstek stałych
HU1000407D0 (en) Ph dependent spaced pharmaceutical composition of modified release
LT2704698T (lt) Vaisto forma, skirta aktyvių ingredientų kontroliuojamam atpalaidavimui
HUE037915T2 (hu) Gyógyszerészeti készítmények aktív vegyületek felszabadítására
ZA201304511B (en) An implant for the controlled release of pharmaceutically active agents
ZA201201533B (en) Diminution of particulate material
ZA201301903B (en) Plant disease controlling composition and method for controlling plant disease
EP2467375A4 (en) FORMS OF DEXLANDSOPRAZOLE AND METHOD OF MANUFACTURING THEREOF
ZA201301904B (en) Plant disease controlling composition and method for controlling plant disease
SI2595939T1 (sl) Erodibilno keramično telo
HU1000224D0 (en) Pharmaceutical composition of controlled release
GB0910846D0 (en) Method of making particulate material